Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways

Abstract Oncolytic viruses (OVs) represent a new class of multi-modal Determinants of Unemployment: Empirical Evidence from Indonesia immunotherapies for cancer, with OV-elicited antitumor immunity being key to their overall therapeutic efficacy.Currently, the clinical effectiveness of OV as monotherapy remains limited, and thus investigators have

read more